Abstract
In the 1970s, treatment of erectile dysfunction (ED), the preferred term for impotence [1], was relatively simple. Sex therapy was the treatment of choice for psychogenic ED, and penile prosthesis implantation was the only reasonable treatment option for most men with organic ED. Clinical evaluation of ED was also relatively straightforward: differentiation between psychogenic and organic ED was usually made by taking a detailed sexual and medical history and by performing nocturnal penile tumescence testing.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
NIH Consensus Panel on Impotence: Impotence.)AMA 1993, 270: 83–90.
Lue TF: Impotence: a patient’s goal-directed approach to treatment. World J Urol 1990, 8: 67–74.
Montague DK, Lakin MM: False diagnoses of venous leak impotence. J Urol 1992, 148: 148–149.
Deutsch S, Sherman L: Previously unrecognized diabetes mellitus in sexually impotent men. JAMA 1980, 244: 2430–2432.
Leonard MP, Nickel CI, Morales A: Hyperprolactinemia and impotence: why, when, and how to investigate. J Urol 1989, 142: 992–994.
Zonszein J: Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am 1995, 22: 789–802.
Hartmann U: Psychological subtypes of erectile dysfunction: results of statistical analyses and clinical practice. World) Uro11997, 15:56–64.
Lakin MM: Diagnostic assessment of disorders of male sexual function. In Disorders of Male Sexual Function. Edited by Montague DK. Chicago: Year Book Medical Publishers; 1988: 26–43.
Wessells H, Lue TF, McAninch JW: Penile length in the flaccid and erect states: guidelines for penile augmentation. J Urol 1996, 156: 995–997.
Lue TF, Donatucci CF: The combined intracavernous injection and stimulation test: diagnostic accuracy. J Urol 1992, 184: 61–62.
Martins FE, Reis JP: Visual erotic stimulation test for initial screening of psychogenic erectile dysfunction: a reliable noninvasive alternative? J Urol 1997, 157: 134–139.
Montague DK, Lakin MM, Medendorp SV, Tesar LJ: Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction. J Urol 1991, 145: 768–771.
Broderick GA, Arger PA: Penile blood flow study: age specific reference ranges. J Urol 1994, 151: A371.
Broderick GA: Noninvasive arterial evaluation of the patient complaining of erectile dysfunction with color duplex Doppler ultrasound. In Diagnosis and Management of Male Sexual Dysfunction. Edited by Mulcahy JJ. New York, Tokyo: lgaku-Shoin; 1997: 89–126.
Padma-Nathan H, Gasior B, Roddy T, et alDynamic infusion cavernosometry and cavernosography (DICC): the interaction of arterial and veno-occlusive function [abstract]. J Urol 1989, 141:221A.
Benet AE, Rehman J, Melman A: Penile revascularization. In Diagnosis and Management of Male Sexual Dysfunction. Edited by Mulcahy JJ. New York, Tokyo: Igaku-Shoin; 1997: 127–147.
Fisher C, Schiavi RC, Edwards A, et al Evaluation of nocturnal penile tumescence in the differential diagnosis of sexual impotence: a quantitative study. Arch Gen Psychiatry 1979, 36:431–437.
Karacan I: The Developmental Aspect and the Effect of Certain Clinical Conditions upon Penile Erection during Sleep: International Congress Series. Princeton, NJ: Excerpta Medica; 1966.
Daitch JA, Lakin MM, Montague DK: Nocturnal penile tumescence monitoring. In Diagnosis and Management of Male Sexual Dysfunction (Topics in Clinical Urology). Edited by Mulcahy JJ. Tokyo: Igaku-Shoin; 1997: 55–73.
Barry JM, Blank B, Boileau M: Nocturnal penile tumescence monitoring with stamps. Urology 1980, 15: 171–172.
Ek A, Bradley WE, Krane RI: Nocturnal penile rigidity measured by the Snap-Gauge band. J Urol 1983, 129: 964–966.
Wein AJ, Fishkin R, Carpiniello VL, Malloy TR: Expansion without significant rigidity during nocturnal penile tumescence testing: a potential source of misinterpretation. J Urol 1981, 126: 343–344.
Bradley WE, Timm GW, Gallagher JM, et al New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology 1985, 26:4–9.
Goldstein I, Lue TF, Padma-Nathan H, et al Oral sildenafil in the treatment of erectile dysfunction: Sildenafil Study Group. N Engl J Med 1998, 339:1397–1404.
Hellstrom WJ, Gittleman M, Karlin G, et al Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. Urology 2003, 61 (suppl 1):8–14.
Porst H, Padma-Nathan H, Giuliano F, et al Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology2003, 62:121–125.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Montague, D.K., Lakin, M.M. (2004). Office Evaluation and Diagnostic Testing for Erectile Dysfunction. In: Lue, T.F. (eds) Atlas of Male Sexual Dysfunction. Current Medicine Group, London. https://doi.org/10.1007/978-1-4613-1087-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1087-7_2
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-0811-0
Online ISBN: 978-1-4613-1087-7
eBook Packages: Springer Book Archive